SCHEMBL1122544

SCHEMBL1122544

COC(=O)[C@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)c1ccc(OCc2ccccc2F)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.67
GAA P10253 1/20 0.67
PTPN1 P18031 4/20 0.62
PTPN2 P17706 2/20 0.62
CDC25B P30305 2/20 0.62
PPARG P37231 1/20 0.59
ERAP2 Q6P179 1/20 0.59
LNPEP Q9UIQ6 1/20 0.59
KMT2A Q03164 2/20 0.58
GPR132 Q9UNW8 2/20 0.53
NPC1 O15118 2/20 0.53
CASP3 P42574 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53
SENP7 Q9BQF6 1/20 0.53
MAOB P27338 1/20 0.52
YAP1 P46937 2/20 0.51
LTA4H P09960 1/20 0.51
LPAR1 Q92633 1/20 0.51
LPAR5 Q9H1C0 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1122851 0.91 PTPN1 (0.74) RAB9APTPN1PTPN2CDC25BPPARG
SCHEMBL1123055 0.91 GAA (0.80) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL27658917 0.89 GAA (0.68) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL1122871 0.89 GAA (0.68) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL1123258 0.88 GAA (0.67) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL1122742 0.88 GAA (0.67) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL1123095 0.88 GAA (0.67) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL1122843 0.88 GAA (0.67) RAB9AGAAPTPN1PPARGERAP2
SCHEMBL27638053 0.87 GAA (0.63) RAB9AGAAPTPN1PTPN2CDC25B
SCHEMBL1123041 0.87 GAA (0.63) RAB9AGAAPTPN1PTPN2CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP claimed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US claimed
EP-1644321-B1 NEW BENZAMIDES AS PPATY MODULATORS S A L V A T LAB SA (ES) 2011-02-09 EP disclosed
US-20060160894-A1 Benzamides as ppar modulators LABORATORIOS S.A.L.V.A.T.,S.A. (ES) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160894-A1 Benzamides as ppar modulators PPARD, PPARA, PPARG RAB9A 4567/4885GAA 3048/4885PTPN1 2708/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.